What We Do
Of the 50 Million embryos produced by in vitro fertilization techniques every year, about 70% fail to implant because current selection techniques are subjective, non-parameterizable, and lack accuracy.
To meet this challenge, we are developing an AI-powered technology convergence platform capable of analyzing clinical patient data, embryo metabolomic information, genetic profiles, and morphokinetic imaging of embryo development. This will enable us to provide revolutionary insight into the implantation potential of each embryo.
Data Selection
Our platform analyzes and interprets thousands of clinical data samples, time-lapse images, genomic and metabolomic information sets to optimize the decision-making process at each stage of Assisted Reproduction Treatment (ART).
Metabolomics
Our novel biotechnological approach involves analyzing the metabolism of embryos to identify molecular profiles related to embryo implantation. By examining the metabolites that the embryos exchange with the culture medium around them, we are able to obtain vital information about their implantation potential in an entirely non-invasive way.
Artificial Intelligence
We enhance the day-to-day procedures and processes of ART with artificial intelligence. The information that we collate is introduced into an AI neural network that provides an implantation prediction score, thereby elevating the probability of a successful outcome.
Final Score
Through this innovative convergence of multiple technologies, we are able to deliver an accurate panel of results. In doing so, we are proud to establish a new evidence-based paradigm that increases precision levels by harnessing predictive scores for each stage of an ART.
Impact
We increase the chances of achieving pregnancy in less time and at a lower cost, ensuring more positive outcomes for those hoping for a baby.
Our Team
Delfina Vilieri
CEO / INDUSTRIAL ENGINEER
Iván Anduaga Marchetti
COO / EMBRYOLOGIST
Paula Sacur Silvestre
FOUNDER / EMBRYOLOGIST
Mario Gadan
FOUNDER / MEDICAL PHYSICS ENGINEER
Federico Díaz
FOUNDER / BIOENGINEER
Advisors
Marisa Martinelli
ADVISOR / METABOLOMICS
Elmer Fernández
ADVISOR / BIOINFORMATICS
Our Values
Respect for patients, clinics, partners, respect for life
Commitment to ethical and scientific standards
Passion for innovation
Proficiency, our experience as a value
Partners
Awards
2020
2020
2021
2021
2021
2020
ANR Emprendedores
Reactivación
Productiva
2020
ANR Emprende
Industria
2021
ANR Emprendedores
de innovación
2021
MSD CONICET
2021
MERK&CONICET
Our Newsletter
info@embryoxite.life
Embryoxite marca registrada. Todos los derechos reservados.